Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease

Autor: Jasmijn A M Sleutjes, Jeanine E Roeters van Lennep, C Janneke van der Woude, Annemarie C de Vries

Publikováno v: Inflammatory Bowel Diseases, 29(4), 531-538. Oxford University Press

Background Dyslipidemia may be an important modifiable risk factor contributing to the increased cardiovascular risk in inflammatory bowel disease (IBD). The lipid metabolism is subject to both systemic inflammation and drug therapy; however, it is u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63fa5db46247e5bee7dbecd8246a1463
http://www.scopus.com/inward/record.url?scp=85146626867&partnerID=8YFLogxK

Cardiovascular risk profiles in patients with inflammatory bowel disease differ from matched controls from the general population

Autor: Jasmijn A M Sleutjes, C Janneke van der Woude, P J Pepijn Verploegh, Elif Aribas, Maryam Kavousi, Jeanine E Roeters van Lennep, Annemarie C de Vries

Publikováno v: European Journal of Preventive Cardiology.

Aims Inflammatory bowel disease (IBD) is associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD). We compared cardiovascular disease (CVD) risk factors and 10-year risk in IBD patients to the general population. Methods an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::df3013bb11482c84af3e451af0320d5e
https://doi.org/10.1093/eurjpc/zwad124

Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management

Autor: C. Janneke van der Woude, Jasmijn A M Sleutjes, Annemarie C. de Vries, Jeanine E. Roeters van Lennep

Publikováno v: Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Therapeutic Advances in Gastroenterology, 14, 1-19. SAGE Publications Ltd
Therapeutic Advances in Gastroenterology

Inflammatory bowel disease (IBD) is associated with an increased risk of cardiovascular disease (CVD). The increased risk of CVD concerns an increased risk of venous thromboembolism (VTE), atherosclerotic cardiovascular disease (ASCVD) and heart fail

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea499956fc0ffc2fcbe3a2f90824b96
https://doi.org/10.1177/17562848211032126

Effect of drug therapy on the lipid profiles of patient with inflammatory bowel disease: A systematic review and meta-analysis

Autor: Jasmijn A M Sleutjes, A C de Vries, C.J. van der Woude, Eric Boersma, J.E. Roeters van Lennep

Publikováno v: Atherosclerosis. 331:e36-e37

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8371f5f02b5a4f3b36187f9bb3c43636
https://doi.org/10.1016/j.atherosclerosis.2021.06.105

P665 Cardiovascular risk profile in chronic auto-inflammatory diseases: a cross-sectional single center study

Autor: J.E. Roeters van Lennep, C.J. van der Woude, M Vis, A C de Vries, M.B.A. van Doorn, Jasmijn A M Sleutjes, P.J.P. Verploegh

Publikováno v: Journal of Crohn's and Colitis. 15:S589-S590

Background Chronic auto-inflammatory diseases are associated with an increased risk of arterial and venous cardiovascular diseases (CVD). Pathogenesis may be related to chronic inflammation and/or traditional CVD risk factors. We aimed to assess the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5c0e6b8047b5c01c15aecceb3559434a
https://doi.org/10.1093/ecco-jcc/jjab076.785